These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9869128)

  • 1. Fluoroquinolones and tuberculosis.
    Yew WW; Chau CH
    Int J Tuberc Lung Dis; 1998 Dec; 2(12):1050-2. PubMed ID: 9869128
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
    Grimaldo ER; Tupasi TE; Rivera AB; Quelapio MI; Cardaño RC; Derilo JO; Belen VA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
    Chierakul N; Klomsawat D; Chulavatnatol S; Chindavijak B
    Int J Tuberc Lung Dis; 2001 Mar; 5(3):278-82. PubMed ID: 11326828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficiency of lomefloxacine in combined treatment of patients with multiresistant pulmonary tuberculosis complicated with nonspecific bronchopulmonary infection].
    Mishin VIu; Vasil'eva IA; Martynova LP
    Probl Tuberk; 1999; (6):20-2. PubMed ID: 10715950
    [No Abstract]   [Full Text] [Related]  

  • 5. Ofloxacin in multidrug resistant tuberculosis.
    Walwaikar PP; Morye VK; Gawde AS
    J Indian Med Assoc; 2003 Mar; 101(3):210-2. PubMed ID: 14603981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TB should be diagnosed before using a fluoroquinolone.
    Agarwal A
    BMJ; 2003 Jul; 327(7407):164-5. PubMed ID: 12869473
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
    Ramarokoto H; Andrianasolo D; Rasolonavalona T; Ramaroson F; Razafitsiarovana I; Vincent V; Ratsimba L; Rasolofo Razanamparany V
    Arch Inst Pasteur Madagascar; 2003; 69(1-2):37-40. PubMed ID: 15678814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report.
    Berning SE; Cherry TA; Iseman MD
    Clin Infect Dis; 2001 Feb; 32(4):643-6. PubMed ID: 11181130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro antituberculous activity of ofloxacin and levofloxacin against multidrug-resistant tuberculosis and clinical outcomes].
    Tada A; Kawata N; Shibayama T; Takahashi S; Hirano A; Kimura G; Takeuchi M; Okada C; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):337-44. PubMed ID: 16715942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
    Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections.
    Berning SE; Madsen L; Iseman MD; Peloquin CA
    Am J Respir Crit Care Med; 1995 Jun; 151(6):2006-9. PubMed ID: 7767552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of new quinolones as antituberculosis drugs].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 1999 Jan; 74(1):71-5. PubMed ID: 10067058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superficial fungal infection of the skin during treatment of tuberculosis.
    Yew WW; Chau CH; Lee J
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1132. PubMed ID: 12546127
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combination chemotherapy of drug-resistant tuberculosis with inclusion of ofloxacin (zanocin)].
    Padeĭskaia EN
    Antibiot Khimioter; 2001; 46(8):9-18. PubMed ID: 11871320
    [No Abstract]   [Full Text] [Related]  

  • 15. Fourth-generation fluoroquinolones in tuberculosis.
    Rieder HL
    Lancet; 2009 Apr; 373(9670):1148-9. PubMed ID: 19345815
    [No Abstract]   [Full Text] [Related]  

  • 16. Levofloxacin for drug-resistant Mycobacterium tuberculosis.
    Peloquin CA; Berning SE; Huitt GA; Iseman MD
    Ann Pharmacother; 1998 Feb; 32(2):268-9. PubMed ID: 9496417
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
    Chulavatnatol S; Chindavijak B; Chierakul N; Klomsawat D
    J Med Assoc Thai; 2003 Aug; 86(8):781-8. PubMed ID: 12948278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients].
    Ye Z; Pei X; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):234-6. PubMed ID: 10072811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levofloxacin in the treatment of drug-resistant tuberculosis.
    Yew WW; Au KF; Lee J; Chau CH
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):89. PubMed ID: 9441068
    [No Abstract]   [Full Text] [Related]  

  • 20. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro.
    Polachek H; Holcberg G; Sapir G; Tsadkin-Tamir M; Polachek J; Katz M; Ben-Zvi Z
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):61-5. PubMed ID: 16154040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.